Logo image of ACKB.BR

ACKERMANS & VAN HAAREN (ACKB.BR) Stock Fundamental Analysis

EBR:ACKB - Euronext Brussels - BE0003764785 - Common Stock - Currency: EUR

204.8  -1.8 (-0.87%)

Fundamental Rating

4

Taking everything into account, ACKB scores 4 out of 10 in our fundamental rating. ACKB was compared to 40 industry peers in the Construction & Engineering industry. While ACKB is still in line with the averages on profitability rating, there are concerns on its financial health. ACKB is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ACKB was profitable.
In the past year ACKB had a positive cash flow from operations.
ACKB had positive earnings in each of the past 5 years.
Each year in the past 5 years ACKB had a positive operating cash flow.
ACKB.BR Yearly Net Income VS EBIT VS OCF VS FCFACKB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.25%, ACKB is in line with its industry, outperforming 55.00% of the companies in the same industry.
ACKB has a Return On Equity (12.51%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 6.76%, ACKB is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 3.25%
ROE 12.51%
ROIC 6.76%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACKB.BR Yearly ROA, ROE, ROICACKB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of ACKB (7.39%) is better than 77.50% of its industry peers.
In the last couple of years the Profit Margin of ACKB has declined.
ACKB has a better Operating Margin (8.99%) than 70.00% of its industry peers.
ACKB's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 37.09%, ACKB is in line with its industry, outperforming 57.50% of the companies in the same industry.
In the last couple of years the Gross Margin of ACKB has declined.
Industry RankSector Rank
OM 8.99%
PM (TTM) 7.39%
GM 37.09%
OM growth 3Y6.69%
OM growth 5Y4.48%
PM growth 3Y-6.91%
PM growth 5Y-3.82%
GM growth 3Y-10.42%
GM growth 5Y-5.22%
ACKB.BR Yearly Profit, Operating, Gross MarginsACKB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACKB is destroying value.
There is no outstanding debt for ACKB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACKB.BR Yearly Shares OutstandingACKB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
ACKB.BR Yearly Total Debt VS Total AssetsACKB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

ACKB has an Altman-Z score of 1.04. This is a bad value and indicates that ACKB is not financially healthy and even has some risk of bankruptcy.
ACKB has a Altman-Z score of 1.04. This is amonst the worse of the industry: ACKB underperforms 80.00% of its industry peers.
ACKB has a debt to FCF ratio of 9.05. This is a negative value and a sign of low solvency as ACKB would need 9.05 years to pay back of all of its debts.
ACKB has a Debt to FCF ratio of 9.05. This is in the lower half of the industry: ACKB underperforms 62.50% of its industry peers.
ACKB has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
ACKB has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: ACKB outperforms 55.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.05
Altman-Z 1.04
ROIC/WACC0.88
WACC7.65%
ACKB.BR Yearly LT Debt VS Equity VS FCFACKB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

ACKB has a Current Ratio of 0.74. This is a bad value and indicates that ACKB is not financially healthy enough and could expect problems in meeting its short term obligations.
ACKB has a Current ratio of 0.74. This is amonst the worse of the industry: ACKB underperforms 92.50% of its industry peers.
ACKB has a Quick Ratio of 0.74. This is a bad value and indicates that ACKB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ACKB (0.70) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.7
ACKB.BR Yearly Current Assets VS Current LiabilitesACKB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B 8B

7

3. Growth

3.1 Past

ACKB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.27%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.40% on average over the past years.
Looking at the last year, ACKB shows a very strong growth in Revenue. The Revenue has grown by 71.00%.
Measured over the past years, ACKB shows a small growth in Revenue. The Revenue has been growing by 7.19% on average per year.
EPS 1Y (TTM)66.27%
EPS 3Y4.64%
EPS 5Y3.4%
EPS Q2Q%101.44%
Revenue 1Y (TTM)71%
Revenue growth 3Y11.91%
Revenue growth 5Y7.19%
Sales Q2Q%116.31%

3.2 Future

The Earnings Per Share is expected to grow by 10.00% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.53% on average over the next years. This is quite good.
EPS Next Y17.56%
EPS Next 2Y10%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.11%
Revenue Next 2Y14.1%
Revenue Next 3Y9.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACKB.BR Yearly Revenue VS EstimatesACKB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
ACKB.BR Yearly EPS VS EstimatesACKB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.15, the valuation of ACKB can be described as very reasonable.
ACKB's Price/Earnings ratio is a bit cheaper when compared to the industry. ACKB is cheaper than 80.00% of the companies in the same industry.
ACKB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.89.
ACKB is valuated reasonably with a Price/Forward Earnings ratio of 11.84.
The rest of the industry has a similar Price/Forward Earnings ratio as ACKB.
The average S&P500 Price/Forward Earnings ratio is at 21.98. ACKB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.15
Fwd PE 11.84
ACKB.BR Price Earnings VS Forward Price EarningsACKB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACKB indicates a slightly more expensive valuation: ACKB is more expensive than 60.00% of the companies listed in the same industry.
77.50% of the companies in the same industry are more expensive than ACKB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.17
EV/EBITDA 11.36
ACKB.BR Per share dataACKB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.58
PEG (5Y)2.98
EPS Next 2Y10%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.21%, ACKB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.60, ACKB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, ACKB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

On average, the dividend of ACKB grows each year by 6.12%, which is quite nice.
Dividend Growth(5Y)6.12%
Div Incr Years4
Div Non Decr Years5
ACKB.BR Yearly Dividends per shareACKB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

ACKB pays out 16.86% of its income as dividend. This is a sustainable payout ratio.
ACKB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP16.86%
EPS Next 2Y10%
EPS Next 3YN/A
ACKB.BR Yearly Income VS Free CF VS DividendACKB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B
ACKB.BR Dividend Payout.ACKB.BR Dividend Payout, showing the Payout Ratio.ACKB.BR Dividend Payout.PayoutRetained Earnings

ACKERMANS & VAN HAAREN

EBR:ACKB (3/27/2025, 11:21:59 AM)

204.8

-1.8 (-0.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-28 2025-02-28/amc
Earnings (Next)05-22 2025-05-22
Inst Owners12.75%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.79B
Analysts80
Price Target218.86 (6.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend2.75
Dividend Growth(5Y)6.12%
DP16.86%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)4.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.96%
Revenue NY rev (3m)-1.46%
Valuation
Industry RankSector Rank
PE 10.15
Fwd PE 11.84
P/S 0.76
P/FCF 6.17
P/OCF 4.82
P/B 1.29
P/tB 1.4
EV/EBITDA 11.36
EPS(TTM)20.17
EY9.85%
EPS(NY)17.29
Fwd EY8.44%
FCF(TTM)33.17
FCFY16.2%
OCF(TTM)42.53
OCFY20.77%
SpS269.27
BVpS159.18
TBVpS145.95
PEG (NY)0.58
PEG (5Y)2.98
Profitability
Industry RankSector Rank
ROA 3.25%
ROE 12.51%
ROCE 8.23%
ROIC 6.76%
ROICexc 8.54%
ROICexgc 9.05%
OM 8.99%
PM (TTM) 7.39%
GM 37.09%
FCFM 12.32%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y6.69%
OM growth 5Y4.48%
PM growth 3Y-6.91%
PM growth 5Y-3.82%
GM growth 3Y-10.42%
GM growth 5Y-5.22%
F-Score8
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.05
Debt/EBITDA 2.06
Cap/Depr 70.44%
Cap/Sales 3.47%
Interest Coverage 12.46
Cash Conversion 113.47%
Profit Quality 166.6%
Current Ratio 0.74
Quick Ratio 0.7
Altman-Z 1.04
F-Score8
WACC7.65%
ROIC/WACC0.88
Cap/Depr(3y)108.72%
Cap/Depr(5y)96.92%
Cap/Sales(3y)8.38%
Cap/Sales(5y)7.72%
Profit Quality(3y)107.38%
Profit Quality(5y)117.68%
High Growth Momentum
Growth
EPS 1Y (TTM)66.27%
EPS 3Y4.64%
EPS 5Y3.4%
EPS Q2Q%101.44%
EPS Next Y17.56%
EPS Next 2Y10%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)71%
Revenue growth 3Y11.91%
Revenue growth 5Y7.19%
Sales Q2Q%116.31%
Revenue Next Year25.11%
Revenue Next 2Y14.1%
Revenue Next 3Y9.53%
Revenue Next 5YN/A
EBIT growth 1Y90.3%
EBIT growth 3Y19.39%
EBIT growth 5Y11.99%
EBIT Next Year152.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y406.47%
FCF growth 3Y33.46%
FCF growth 5Y68.25%
OCF growth 1Y116.56%
OCF growth 3Y21.73%
OCF growth 5Y19.25%